These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33318483)

  • 1. Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes.
    Verardi R; Lindesmith LC; Tsybovsky Y; Gorman J; Chuang GY; Edwards CE; Brewer-Jensen PD; Mallory ML; Ou L; Schön A; Shi W; Tully ES; Georgiou G; Baric RS; Kwong PD
    NPJ Vaccines; 2020 Dec; 5(1):110. PubMed ID: 33318483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.
    Parra GI; Bok K; Taylor R; Haynes JR; Sosnovtsev SV; Richardson C; Green KY
    Vaccine; 2012 May; 30(24):3580-6. PubMed ID: 22469864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
    Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
    Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice.
    Hou W; Lv L; Wang Y; Xing M; Guo Y; Xie D; Wei X; Zhang X; Liu H; Ren J; Zhou D
    Front Immunol; 2022; 13():906275. PubMed ID: 35711416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotypic humoral and cellular immune responses following Norwalk virus infection.
    Lindesmith LC; Donaldson E; Leon J; Moe CL; Frelinger JA; Johnston RE; Weber DJ; Baric RS
    J Virol; 2010 Feb; 84(4):1800-15. PubMed ID: 20007270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norovirus GII.4 strain antigenic variation.
    Lindesmith LC; Donaldson EF; Baric RS
    J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses.
    Lindesmith LC; Beltramello M; Swanstrom J; Jones TA; Corti D; Lanzavecchia A; Baric RS
    Open Forum Infect Dis; 2015 Sep; 2(3):ofv084. PubMed ID: 26180833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
    Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.
    Springer MJ; Ni Y; Finger-Baker I; Ball JP; Hahn J; DiMarco AV; Kobs D; Horne B; Talton JD; Cobb RR
    Vaccine; 2016 Mar; 34(12):1452-8. PubMed ID: 26873053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
    Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analyses of the GI.4 norovirus by cryo-electron microscopy and X-ray crystallography revealing binding sites for human monoclonal antibodies.
    Kimura-Someya T; Katsura K; Kato-Murayama M; Hosaka T; Uchikubo-Kamo T; Ihara K; Hanada K; Sato S; Murayama K; Kataoka M; Shirouzu M; Someya Y
    J Virol; 2024 May; 98(5):e0019724. PubMed ID: 38593321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.